Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Retrospective evaluation of laboratory data of patients with telogen effluvium

Fatma Tuncez Akyurek, Gozde Ulutas Demirbas, Abdullah Demirbas, Fikret Akyurek, Gulcan Saylam Kurtipek.




Abstract
Cited by 5 Articles

Aim: Telogen effluvium (TE) is a diffuse non-cicatricial alopecia that is frequently encountered in daily practice. This study aimed to evaluate laboratory data (whole blood count (WBC), iron (Fe), iron binding capacity (TIBC), ferritin, B12 and vitamin D, Zinc (Zn)) of female patients with chronic TE.
Material and Methods: One hundred seventy nine female patients who applied to Selçuk University Faculty of Medicine Hospital’s dermatology polyclinic between June 2015 and March 2017 with chronic TE (TE complaint of longer than 6 months) were included in the study.
Results: The mean age of the patients was 24±7.4 years. The levels of hemoglobin (HGB) (8.9%) and hematocrit (HCT) (8.9%) , mean corpuscular volume (MCV) (16.2%), Fe (16.8% ) , vitamin B12 (15.1%), Zinc (62%) and vitamin D (68.7%) were lower, TIBC (39.7%) level was higher than the reference range.
Conclusion: Although the examinations related to the chronic TE etiology are not clear, we think that laboratory evaluation should be performed for the parameters of vitamin D, B12, Zn and anemia in these patients and the remedy of their deficiencies through supplements may be useful in the treatment.

Key words: Iron; telogen effluvium; vitamin B12; vitamin D; zinc






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.